Intravascular Imaging Market Embraces AI Innovation and Expanding Cardiovascular Applications

Intravascular Imaging Market Size and Forecast 2025 to 2034

The global intravascular imaging market size was estimated at USD 411.37 billion in 2024 and is predicted to increase from USD 433.67 billion in 2025 to approximately USD 697.37 billion by 2034, expanding at a CAGR of 5.42% from 2025 to 2034. Increased usage of intravascular imaging modalities is expected to boost the intravascular imaging market growth.

Intravascular Imaging Market Key Takeaways

• In terms of revenue, the global intravascular imaging market was valued at USD 411.37 billion in 2024.
• It is projected to reach USD 697.37 billion by 2034.
• The market is expected to grow at a CAGR of 5.42% from 2025 to 2034.
• North America held a significant share of the global intravascular imaging market.
• Asia Pacific is expected to grow at the fastest rate in the market throughout the studied period.
• By product type, the instrument segment dominated the market in 2024.
• By product type, the software segment is expected to grow at the fastest rate in the market over the forecast period.
• By modality, the trolley mounted segment led the market in 2024.
• By modality, the handheld segment is anticipated to witness the fastest growth in the market during the projected period.
• By the end-use, in 2023, the hospital segment dominated the global market.
• By end-use, the ambulatory surgical centers segment is projected to show the fastest growth in the market over the forecast period.

AI Impact on the Intravascular Image Market

Algorithms have the potential to significantly improve intravascular imaging by automating numerous tasks or calculations, uncovering new patterns or phenotypes in data, and offering alternative diagnostic insights. Moreover, In the realm of interventional cardiology, artificial intelligence (AI) can contribute to procedural guidance, enhance intravascular imaging, and provide supplementary information to operators. As AI progressively extends into interventional cardiology, it can fundamentally transform the intravascular imaging market.

• In October 2023, Evident Vascular, a medical technology startup developing an intravascular ultrasound (IVUS) platform leveraging artificial intelligence to enable superior imaging and streamlined workflows, announced that it has launched with a USD 35 million Series A financing from Vensana Capital. Evident Vascular is addressing a critical need in the IVUS market, making it an ideal company to add to our vascular technology innovations.

Market Overview

The intravascular imaging market includes cutting-edge medical imaging technologies designed for visualizing and assessing coronary arteries and blood vessels. Techniques such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are integral to diagnosing cardiovascular conditions and directing interventional treatments like angioplasty and stent placement. This innovative field of intravascular imaging transforms cardiovascular diagnostics and interventions by utilizing specialized methods to visualize the inner structures of arteries and veins directly within the blood vessels.

Intravascular Imaging Market Growth Factors

• The rising need for consistent picture output quality can fuel the intravascular imaging market growth soon.
• Ongoing technological advancements in intravascular imaging devices can fuel the intravascular imaging market growth further.
• Growing awareness among healthcare professionals regarding intravascular imaging is also expected to drive the intravascular imaging market growth.

Market Scope

Market Dynamics

Driver

Expanded applications in peripheral vascular and structural heart procedures

The intravascular imaging market is growing beyond its traditional focus on coronary interventions, now embracing a wider range of applications in peripheral vascular and structural heart procedures. This broadening scope creates new opportunities for growth and market penetration. The potential for expansion extends into peripheral vascular and structural heart procedures, moving beyond conventional coronary interventions.

• In August 2023, GE HealthCare launched a new wireless ultrasound imaging system. The system helps clinicians view clear cardiac and vascular images at the point of care. The new system features SignalMax and XDclear technology, facilitating better resolution, penetration, and sensitivity in imaging performance using single-crystal transducer technology.

Restraint

Concerns regarding radiation exposure

Some intravascular imaging methods, like fluoroscopy, involve exposure to ionizing radiation, raising concerns about the potential health risks. These concerns might affect the adoption of these technologies and shape preferences among patients and healthcare providers. Additionally, the absence of standardization in both procedures and interpretations of intravascular imaging presents challenges that can hinder the intravascular imaging market growth.

Opportunity

Integration of ultrasound imaging

A notable trend in the intravascular imaging market is the integration of intravascular ultrasound with other imaging techniques, such as angiography and optical coherence tomography (OCT). This combination enhances diagnostic and imaging capabilities by providing a more comprehensive view. Healthcare providers aim to improve patient outcomes and reduce costs, which supports the continuation of this trend in the coming years. Furthermore, advancements are being made with more refined IVUS catheters, which feature smaller diameters and make the imaging of narrower blood vessels. Hence, IVUS technology is anticipated to become more prevalent across various healthcare settings due to the increasing demand for minimally invasive diagnostic and therapeutic solutions.

• In May 2024, Spryte Medical, an intravascular imaging, and AI company announced the publication of their first-in-human study of its neuro Optical Coherence Tomography (CT) technology in the peer-reviewed journal Science Translational Medicine, entitled Volumetric microscopy of cerebral arteries with a miniaturized optical coherence tomography imaging probe.

Product Type Insights

The instrument segment dominated the intravascular imaging market in 2024. In the Intravascular Imaging market, the instrument segment encompasses the medical devices and equipment utilized for imaging procedures within blood vessels. Additionally, these instruments are essential for diagnosing and managing cardiovascular diseases, as they offer high-resolution visuals of arteries and blood vessels. Detailed images assist cardiologists and healthcare professionals in evaluating vascular conditions, detecting blockages, and directing therapeutic interventions.

The software segment is expected to grow at the fastest rate in the intravascular imaging market over the forecast period. This is because Software is important in improving data analysis and interpretation and provides advanced processing and visualization features that complement imaging instruments. This aspect is expected to drive continued growth in the segment throughout the forecast period.

Modality Insights

The trolley mounted segment led the intravascular imaging market in 2024. This segment provides versatility and facilitates convenient transportation and positioning during cardiovascular procedures. Trolley stands, and Cassette holders need to be tailored to suit individual patients. A variety of trolley stands and cassette holders are available to meet these needs. The transition from traditional analog X-ray technology to computer-aided radiography improves image communication and offers environmental benefits for you to take full advantage of the improved technology.

The handheld segment is anticipated to witness the fastest growth in the intravascular imaging market during the projected period. Handheld intravascular imaging devices address the need for point-of-care accessibility and greater procedural flexibility. They enable healthcare providers to perform imaging procedures at the bedside, in outpatient settings, or in scenarios where trolley-mounted systems might not be as suitable.

• In February 2024, Butterfly Network launched a New Handheld Ultrasound System. Offering a combination of enhanced image processing, artificial intelligence (AI) tools, and improved 3D imaging, the Butterfly Network has unveiled the iQ3TM handheld ultrasound. In addition to a ‘no focus’ rubber lens that facilitates improved observation of small anatomical structures, the iQ3 point-of-care device also features 3D imaging advances with iQ Slice and iQ Fan.

End-user Insights

The hospital segment dominated the global intravascular imaging market in 2024. Medical imaging technology is typically found in mid-sized to large hospitals due to its potential to generate substantial outpatient revenue. This segment commands the largest market share, driven by its high utilization rates and extensive patient base.

The ambulatory surgical centers segment is projected to show the fastest growth in the intravascular imaging market over the forecast period. This trend highlights a move towards outpatient cardiovascular interventions. Ambulatory surgical centers (ASCs) provide a more accessible and cost-efficient option, especially for intravascular imaging procedures that involve minimally invasive techniques.

Regional Insights

North America held a significant share of the global intravascular imaging market. This growth is supported by the region's strategic embrace of advanced medical technologies and a strong healthcare infrastructure. In the United States, the market for intravascular imaging technologies is expanding steadily, fueled by the rising prevalence of cardiovascular diseases and the demand for sophisticated diagnostic and interventional tools.

The U.S.’s dedication to healthcare research and development promotes innovation, facilitating the smooth integration of innovative intravascular imaging solutions. The advancements in image quality and device portability have significantly enhanced diagnostic precision and patient outcomes.

Asia Pacific is expected to grow at the fastest rate in the intravascular imaging market throughout the studied period. The upward trajectory of China’s intravascular imaging market is largely driven by a rise in cardiovascular diseases and enhanced healthcare investments. The growing incidence of conditions like coronary artery disease has spurred a demand for advanced diagnostic tools, including intravascular imaging. Additionally, the government’s emphasis on improving healthcare infrastructure and extending services to rural regions has further supported market expansion.

• In January 2023, Sonoscape’s intravascular ultrasound devices were approved in China. Sonoscape Medical Corp. obtained marketing approval in China for its intravascular ultrasound (IVUS) diagnostic device and intravascular ultrasound diagnostic catheter.

Intravascular Imaging Market Companies

• Acqiris
• NIDEK CO. LTD.
• AGFA Healthcare
• Aculight Carl Zeiss AG
• Heidelberg Engineering Inc.
• Optopol
• Sonostar Technologies Co.Ltd.
• OPKO Health
• AlazarTech

Segments Covered in the Report

By Product Type

• Instruments
• Software

By Modality

• Handheld
• Trolley Mounted

By End-user

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers
• Long-term Care Centers
• Others

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa